• Twitter Clean
  • w-facebook

DRW (Europe) Ltd

Suite 12, Science Village

Chesterford Research Park

Little Chesterford, CB10 1XL

UK

© 2019 DRW Ltd.

DRW (US) Ltd

845 Embedded Way

Suite 150

San Jose, CA 95138

USA

NEWS

DRW wins Innovate UK's Design in Innovation Award

United Kingdom

03 November 2016

A shortlist of 10 firms competed for Innovate UK’s Design in Innovation award, and Diagnostics for the Real World was recognized for the development of the SAMBA platform. The award was presented by Wayne Hemmingway, founder of HemmingwayDesign.

Craig Wisniewski, V.P of Engineering & Manufacturing, said, "It’s fantastic to win this award. We’re in good company – everyone at Innovate UK is looking to solve real world problems – in our case HIV. Without Innovate UK we couldn’t have developed the SAMBA diagnostic system. It’s more more than just money, it’s the expertise and oversight that have been so helpful."

DRW presents at ASLM Cape Town

Cape Town, South Africa

December 2016

DRW were once again in attendance at the annual ASLM this year held in Cape Town, South Africa.  In addition to the booth showing the latest SAMBA II instruments they also ran a well attended Symposium titled "What do we really need to successfully implement POC?"

Helen Lee wins European Inventor Award 2016

Lisbon, Portugal

2016

Helen Lee has won the European Inventor Award 2016 Popular Prize from the European Patent Office (EPO)! To everyone who supported us by voting for Dr. Lee, our most heartfelt thanks!

SAMBA II wins in the iF DESIGN AWARD 2015

BMW Welt - Munich

27 February 2015

SAMBA II ia a winner in the iF DESIGN AWARD 2015!

For over 60 years, the iF DESIGN AWARD has been recognized the world over as a label of design excellence. The iF logo is an internationally established symbol identifying outstanding achievements in design.

We are thrilled to let you know that the SAMBA II instruments have received an iF DESIGN AWARD 2015 and that we are among the winners of the renowned iF label. The number of competitors was huge: the international high-profile jury assessed almost 5,000 entries from 53 countries in order to determine who would receive this coveted seal of excellence. 

ASLM2014

Cape Town

30 November til 4 December 2014

SAMBA II Instrument platform is CE marked

Cambridge UK

26 November 2014

Babies get HIV test kits

The Observer (Uganda)

30 September 2014

"Delays associated with conventional early infant diagnosis may be no more with the introduction of a new point of care machine dubbed Samba II.

The portable machine offers results within two hours and does not need centralised laboratories and specialist technicians to carry out the test. Samba II integrates the whole testing process within a single instrument using ready- made disposable cartridges. The results are then received, indicated by a blue line, similar to a pregnancy test.

“These machines will help transform the lives of tens of thousands of HIV-exposed infants who have a 50 per cent chance of early death if HIV is not diagnosed within the first six weeks of life and if they are not immediately initiated on treatment,” Sarah Opendi, the state minister for Primary Health Care, said last week at Kabira Country club.

Opendi was speaking at a training workshop for health care cadres organised by Diagnostics for the Real World (DRW), the producers of this machine. She said over 40 per cent of HIV- positive infants died before they could be initiated on treatment because of delays in receiving results.

The machine is also designed to monitor the viral load in adults on antiretroviral therapy.

“To monitor the viral load, the machine takes less than 90 minutes. Together with the health ministry, we are doing a task-shifting study to evaluate how different health cadres are able to use this technology after training,” said Lourdes Nadala, the DRW director of regulatory and scientific affairs.

The training involves 42 cadres from different regions. After the training, pilot implementation will be conducted in a few health facilities to demonstrate the ease of using Samba II within local settings."

Health ministry launches new HIV testing machine

Daily Monitor (Uganda)

23 September 2014

KAMPALA - The Ministry of Health yesterday rolled out a new transformative point-of-care diagnostic machine which gives instant results for the detection of a genetic material of the HIV virus.

Dubbed, SAMBA II, the highly portable machine enables medics to determine the baby’s HIV status within two hours and 90 minutes for motoring viral loads in mature patients, this provides a better solution to the current screening process where samples are faced with transportation challenges to the Central Public Health Laboratory.
According to the Minister of State for Primary Health Care, Ms Sarah Opendi, the convectional platforms for DNA based HIV tests takes many hours to perform and requires specialised facilities and highly-trained personnel.

“This point of care machine will help transform the lives of tens of thousands of HIV exposed infants who have a 50 per cent chance of early death if HIV infection is noted diagnosed within the first six weeks of life,” said Ms Opendi.

She added in the current early infant HIV diagnosis (EID), more than 40 per cent of positive infants are lost in terms of follow up before they can be initiated on treatment.
“By bringing this rapid test, SAMBA II, resolves these challenges and comes at the right time to improve access to Viral load monitoring services in Uganda,” noted Ms Opendi.

Tested and approved
Speaking on behalf of the technology developers, Ms Lourdes M Nadala, the director of Regulatory and Scientific Affairs at the Diagnostics for Real World, a spin-out company from the University of Cambridge, noted that the technology has been validated in Makerere University, John Hopkins University Collaboration and Arua Regional Referral Hospital together with other laboratories in Kenya, Malawi and Zimbabwe .

“The SAMBA II machine can detect all the HIV Subtypes and has been found to have high sensitivity,” said Ms Nadala, adding that it has already been approved by the Uganda National Council for Science and Technology.

According to Nadala, the technology integrates the whole testing process within a single instrument using ready-made cartridges, and easy to read results are obtained in less than two hours with the whole command process done using a smart phone application.

Meanwhile, a training involving 42 different health workers with varying levels of qualifications from different health facilities across the country is underway to build their capacity in using the technology that requires minimal knowledge.

After the training, Dr Ruth Acheng, the director general at the Ministry of Health, observed that a pilot implementation will be conducted in few health facilities across the country. 

New NIV/AIDS testing kit to test HIV infants hours after birth

NTV Uganda

22 September 2014

Babies who are exposed to HIV from their mothers could soon be tested as early as two hours after birth. This as the Ministry of Health introduces a new machine, Samba II offered by the Diagnostics for the Real World from the University of Cambridge in UK.
It will be used by different health workers to make diagnosis and follow up infected infants. Florence Naluyimba reports on a machine that transforms what was a centralized system.

Babies' HIV status can now be determined upon delivery

NBS (Uganda)

22 September 2014

A new point of care test for HIV has been launched in Uganda.

 

The Simple Amplification Based Assay (SAMBA 2) is the meant for instant HIV testing among infants upon birth.

 

The test is the first of its kind in Uganda and it's expected to improve services in upcountry medical facilities.

 

The machines used are portable therefore are easy to move from one place to another depending on the need.

 

SAMBA two can diagnose newly-infected HIV patients, new-born babies and monitor resistance to anti-retroviral drugs.

 

There have been difficulties in moving the testing equipments from one place to another and the cost attached most areas could not have access to HIV/aids testing.

 

Therefore SAMBA two is expected to reduce such inconveniences.

 

The small, portable machine called SAMBA II, will help transform the lives of millions, especially HIV infants, who have a one in two chance of early death if the HIV infection is not diagnosed and treatment started within the first six weeks of life.

 

The machine is now available in Uganda and Malawi and has recently received product approval in Kenya.

 

It's the first rapid, accurate and cost-effective HIV diagnosis which can be done at the point of care, in even the most environmentally challenging and resource-limited settings.

 

The state minister for primary health care Sarah Opendi presided over the launch.

 

Developed by diagnostic for the real world, a spin-out company from the University of Cambridge founded in 2002 SAMBA II instrument uses innovative technology without relying on centralized laboratories or specialist technicians
SAMBA two can diagnose newly-infected HIV patients, new-born babies and monitor resistance to anti-retroviral drugs.

 

In 2013, the World Health Organization (WHO) recommended routine viral load testing for all people living with HIV in developed and developing countries.

 

The test is being used where need is highest, two-thirds of the estimated 33 million individuals infected with HIV worldwide live in sub-Saharan Africa, where three-quarters of the deaths from AIDS also occur.

 

A team of 42 medical experts across the country are currently undergoing training on how to use the machine. 

Hospitals get HIV/AIDS test machines for new-born babies

Daily Monitor (Uganda)

September 2014

Details of the article on "Hospitals get HIV/AIDS test machines for new-born babies" appeared in the hard copy of the newspaper only.

DRW Melbourne Press Conference Announced

Cambridge UK

8 July 2014

DRW Ltd will be holding a Press Conference on 22nd July at the 2014 International AIds Conference. "SAMBA II offers on-the-spot HIV testing to millions living with HIV in Africa" will focus on the development and impact of the new HIV diagnostic tool.  The Press Conference will be attended by The Honorable Sarah Achieng Opendi (State Minister for Primary Care, Ministry of Health, Uganda), Pete McDermott (CIFF), Helen Lee (DRW-Ltd).

DDU Melbourne Symposium Speakers Announced

Cambridge UK

6 July 2014

Details of the Symposium being organised by the DDU in association with CIFF at the 2014 International Aids Conference were announced today.  Entitled " Point-of-care HIV nucleic acid tests - the next game changer?" the symposium range across a variety of topics from specific field studies to broader strategic visions.

 

Anyone attending the Conference is welcome to attend the Symposium which begins at 3.45 on 20th July 2014.

Zimbabwe Task Shifting Study of SAMBA II to commence in July

Cambridge UK

2 July 2014

A task shifting study involving DRW's SAMBA II HIV PoC system will begin in Zimbabwe in early July it was announced today. Twenty women from villages outside the capital will attend the sessions in Harare where they will be trained to use SAMBA II.  Only a day sfter they have themselves been trained, the first ten of the women will then train others thereby demonstrating the ease with which SAMBA II can be operated by non technicians.  In what is believed to be the first study of its kind, the task-shifting exercise is an important step in the wider SAMBA II implementation programme.  Results of the study will be presented at the Symposium being organised by the DIagnostics Development Unit of the University of Cambridge at the 2014 International Aids Conference in Melbourne.

DDU announce high profile symposium at the International Aids Conference 2014

Cambridge UK

30 June 2014

Dr Helen Lee P Director of Research at the DDU today announced that the unit will host a high profile symposium on the opening day of the 20th International Aids Conference in Melbourne, Australia.  The event, held in association with The Childrens Investment Fund Foundation (CIFF),  is scheduled for 3.45pm on 20 July 2014 .  Further details will be posted here as soon as they are available.

SAMBA II to be demonstrated at World Aids Conference 2014

Cambridge UK

23 May 2014

DRW's SAMBA II - "a fully automated sample in - results out" HIV diagnosis system will be demonstrated at the Company's stand at the World Aids Conference in Melbourne 20-25 July 2014. SAMBA II joins SAMBA I amongst DRW's portfolio of test-and treat diagnostic systems. Using DRW's proven nucleic-acid based amplification technologies, SAMBA II offers a rapid and accurate results and is particularly well suited to EID and viral load measurement in resource-limited settings.  Resistant to dust, high heat and high humidity, SAMBA II has been designed to operate in the most challenging environmental conditions

Distribution Agreement Signed for Southern African

Cambridge UK

20 May 2014

South Africa-based The Scientific Group has been named as DRW's distributor for South Africa, Lesotho, Namibia, Swaziland and Botswana.  In the first of a series of announcements regarding its distribution arrangements, DRW expressed its "great satisfaction" at having reached agreement with The Scientific Group whose reputation for quality service throughout southern Africa has been built up over 25 years.  Further agreements are at an advanced stage and DRW hopes to be able to announce arrangements for distribution in other territories in June and July.

Please reload